Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
NCT: NCT05834478 · RECRUITING
Brief Summary
This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient research hospital stay, have an MRI scan, and have a follow-up call 1-3 months after their inpatient stay. Participants will complete several psychiatric questionnaires/interviews, physiological monitoring with several devices, brain imaging, and VNS testing.
Frequently Asked Questions
What is Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3?
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 is a clinical trial registered under NCT05834478. Current status: RECRUITING.
What is the status of NCT05834478?
The current status of NCT05834478 (Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3) is: RECRUITING.
When did Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 start?
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 started on 2024-02-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.